We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+474.07%
AUM
$8.08B
AUM Growth
+$745M
Cap. Flow
+$329M
Cap. Flow %
4.08%
Top 10 Hldgs %
18.71%
Holding
332
New
33
Increased
130
Reduced
73
Closed
17

Sector Composition

Rank Sector Weight
1 Industrials 26.24%
2 Technology 19.82%
3 Healthcare 17.76%
4 Consumer Discretionary 13.28%
5 Financials 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN.PRA
176
DELISTED
Allergan plc
AGN.PRA
$7.63M 0.09%
8,800
HRTX icon
177
Heron Therapeutics
HRTX
$93.9M
$7.62M 0.09%
549,960
+29,791
+6% +$431K
GHM icon
178
Graham Corp
GHM
$1.12B
$7.58M 0.09%
385,741
+110,380
+40% +$2.36M
AXON
179
Axon Enterprise
AXON
$42.5B
$7.54M 0.09%
300,126
+16,002
+6% +$391K
WY icon
180
Weyerhaeuser
WY
$18B
$7.51M 0.09%
224,104
LSXMA
181
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$7.21M 0.09%
237,593
SSNI
182
DELISTED
Silver Spring Networks, Inc.
SSNI
$7.17M 0.09%
635,303
+25,000
+4% +$270K
POT
183
DELISTED
Potash Corp Of Saskatchewan
POT
$7.08M 0.09%
434,300
+7,500
+2% +$124K
MMSI icon
184
Merit Medical Systems
MMSI
$5.08B
$7.07M 0.09%
185,435
-56,292
-23% -$1.88M
PNNT
185
Pennant Park Investment Corp
PNNT
$215M
$6.99M 0.09%
945,695
+190,265
+25% +$1.47M
CMRX
186
DELISTED
Chimerix, Inc.
CMRX
$6.92M 0.09%
1,270,082
+62,166
+5% +$327K
BIP icon
187
Brookfield Infrastructure Partners
BIP
$19.2B
$6.88M 0.09%
282,492
HSTM icon
188
HealthStream
HSTM
$819M
$6.85M 0.08%
260,309
-38,569
-13% -$1.06M
XNCR icon
189
Xencor
XNCR
$1.5B
$6.79M 0.08%
321,713
+15,842
+5% +$355K
MLAB icon
190
Mesa Laboratories
MLAB
$564M
$6.75M 0.08%
47,070
+2,742
+6% +$390K
BNFT
191
DELISTED
Benefitfocus, Inc.
BNFT
$6.72M 0.08%
185,000
+75,000
+68% +$2.41M
WVE icon
192
Wave Life Sciences
WVE
$1.09B
$6.62M 0.08%
+355,835
New +$7.67M
SNDX icon
193
Syndax Pharmaceuticals
SNDX
$1.69B
$6.52M 0.08%
466,427
-38,270
-8% -$437K
AGIO icon
194
Agios Pharmaceuticals
AGIO
$1.79B
$6.49M 0.08%
126,062
UNP icon
195
Union Pacific
UNP
$174B
$6.47M 0.08%
59,370
PR
196
Permian Resources
PR
$17.8B
$6.45M 0.08%
407,592
-41,500
-9% -$682K
COTY icon
197
Coty
COTY
$2.42B
$6.23M 0.08%
332,116
+100,700
+44% +$1.87M
AGN
198
PUT
DELISTED
Allergan plc
AGN
$6.08M 0.08%
25,000
SIRI icon
199
SiriusXM
SIRI
$9.98B
$6.07M 0.08%
111,025
HEES
200
DELISTED
H&E Equipment Services
HEES
$5.99M 0.07%
293,487
+50,000
+21% +$1.05M

Similar funds

ArrowMark Colorado Holdings's Q2 2017 Portfolio in Review

As of Q2 2017, ArrowMark Colorado Holdings held 332 positions worth $8.08B, up 10% from $7.33B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

ArrowMark Colorado Holdings deployed $329M of net new capital in Q2 2017, opening 33 new positions and adding to 130 existing holdings. Its largest new stake was lululemon athletica: 829,039 shares worth $49.5M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Syneos Health, Inc. Class A Common Stock, an estimated $59.7M trimmed.

  • ArrowMark Colorado Holdings's largest Q2 2017 buy was lululemon athletica: 829,039 shares worth $49.5M.
  • ArrowMark Colorado Holdings added most to Sally Beauty Holdings in Q2 2017, an estimated $46.8M increase.
  • ArrowMark Colorado Holdings's biggest Q2 2017 reduction was Syneos Health, Inc. Class A Common Stock, cutting an estimated $59.7M.
  • ArrowMark Colorado Holdings fully exited CEB Inc. in Q2 2017, selling an estimated $186M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 19% of its $8.08B portfolio in Q2 2017.
  • ArrowMark Colorado Holdings opened 33 new positions and closed 17 in Q2 2017.
  • ArrowMark Colorado Holdings's portfolio value rose 10% quarter-over-quarter to $8.08B.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2017, filed 14 Aug 2017.